1. Home
  2. Directory
  3. Pennsylvania
  4. Palmerton
  5. Podiatrist
  6. NPI Profile
  7. Prescriptions 1790779031

MEETA PANCHOLI DPM
Prescription History 1790779031
Podiatrist in Palmerton, PA


Quality Rating: 79.95 out of 100 score

NPI Status: Active since September 01, 2005

Contact Information

3295 FOREST INN RD
PALMERTON, PA
ZIP 18071
Phone: (610) 826-3338
Fax: (610) 824-7229

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MEETA PANCHOLI DPM, an active Podiatrist specialist practicing in Palmerton, PA. Our medical registry currently tracks 4 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 73 documented patient claims. Among these therapy options, the most frequently utilized medication is Ammonium Lactate, which accounts for 26 claims alone.

Medication Index

A
C
S
No matching medications currently found on file.

Ammonium Lactate

Generic Formulation: Ammonium LactateSpecialty: Podiatry
Provider Metrics Summary
Total Claims 26
30-Day Fills 37.0
Days Supply 1,141
PA State Average Benchmarks
Peer Average Claims37.0
Peer Average 30-Day Fills40.7
Peer Average Days Supply1,143
Conservative Utilization

This provider writes prescriptions for this formulation 29.7% less frequently than the standard regional baseline metric for practitioners inside PA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $782.56 across this reporting matrix range.

Provider Avg Cost Per Claim

$30.10

State Avg Cost Per Claim

$25.67

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)

Therapeutic Applications

This medication is used to treat dry, scaly skin conditions (such as xerosis, ichthyosis vulgaris) and can also help relieve itching from these conditions. This medication works by increasing the moisture in the skin.

Ciclopirox

Generic Formulation: CiclopiroxSpecialty: Podiatry
Provider Metrics Summary
Total Claims 11
30-Day Fills 13.0
Days Supply 359
PA State Average Benchmarks
Peer Average Claims32.0
Peer Average 30-Day Fills35.7
Peer Average Days Supply1,005
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 65.6% less volume than the regional standard for practitioners inside PA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $225.06 across this reporting matrix range.

Provider Avg Cost Per Claim

$20.46

State Avg Cost Per Claim

$34.97

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cyclohexane and pyridinone derivative that is used for the treatment of fungal infections of the skin and nails, and for treatment of VAGINAL YEAST INFECTIONS.

Therapeutic Applications

This medication is used to treat fungal infections of the fingernails and toenails. It is used as part of a treatment program that may include the removal of unattached, infected nails by a health care professional. Ciclopirox works by stopping the growth of fungus.

Clotrimazole-Betamethasone

Generic Formulation: Clotrimazole/Betamethasone DipSpecialty: Podiatry
Provider Metrics Summary
Total Claims 25
30-Day Fills 25.0
Days Supply 554
PA State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills25.4
Peer Average Days Supply567
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across PA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $619.97 across this reporting matrix range.

Provider Avg Cost Per Claim

$24.80

State Avg Cost Per Claim

$30.40

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This combination medication is used to treat a variety of inflamed fungal skin infections such as ringworm, athlete's foot, and jock itch. This product contains 2 medications. Clotrimazole is an azole antifungal that works by preventing the growth of fungus. Betamethasone is a strong corticosteroid that works by reducing the swelling, redness, and itching that occurs in the skin infection. This medication is not recommended for children younger than 17 years or for diaper rash.

Silver Sulfadiazine

Generic Formulation: Silver SulfadiazineSpecialty: Podiatry
Provider Metrics Summary
Total Claims 11
30-Day Fills 16.3
Days Supply 408
PA State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills25.3
Peer Average Days Supply420
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 54.2% less volume than the regional standard for practitioners inside PA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $162.18 across this reporting matrix range.

Provider Avg Cost Per Claim

$14.74

State Avg Cost Per Claim

$16.50

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Antibacterial used topically in burn therapy.

Therapeutic Applications

This medication is used with other treatments to help prevent and treat wound infections in patients with serious burns. Silver sulfadiazine works by stopping the growth of bacteria that may infect an open wound. This helps to decrease the risk of the bacteria spreading to surrounding skin, or to the blood where it can cause a serious blood infection (sepsis). Silver sulfadiazine belongs to a class of drugs known as sulfa antibiotics. Silver sulfadiazine must not be used on premature babies or on newborns during the first 2 months of life because of the risk of serious side effects.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like MEETA PANCHOLI DPM provides transparency into local medical care patterns within Palmerton, PA.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Podiatrist** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.